NCT04542759View on ClinicalTrials.gov

Effect of Topical Besifloxacin on Ocular Surface Bacterial Microbiota Prior to Cataract Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Microbial DiseaseCataract Senile
Interventions
DRUG

Besifloxacin Ophthalmic

Prophylaxis for endophthalmitis

DRUG

Hydroxypropyl Methylcellulose Ophthalmic Ophthalmic Solution

Placebo

Trial Locations (1)

06800

Institute of Ophthalmology, Conde de Valenciana Foundation, Mexico City

All Listed Sponsors
lead

Instituto de Oftalmología Fundación Conde de Valenciana

OTHER

NCT04542759 - Effect of Topical Besifloxacin on Ocular Surface Bacterial Microbiota Prior to Cataract Surgery | Biotech Hunter | Biotech Hunter